Pharmaceutical Quality Submissions to Food & Drug Administration (PQ/CMC)
0.1.20 - Build CI United States of America flag

Pharmaceutical Quality Submissions to Food & Drug Administration (PQ/CMC), published by HL7 International / Biomedical Research and Regulation. This guide is not an authorized publication; it is the continuous build for version 0.1.20 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/FHIR-us-pq-cmc/ and changes regularly. See the Directory of published versions

Example PlanDefinition: A quality specification is for a drug substance

Active as of 2022-12-08

Generated Narrative: PlanDefinition

Resource PlanDefinition "cc82a0ce-b72f-4d58-8ea0-6f323e2a9a93"

Profile: Quality Specification

Specification Type: Drug Substance (Dummy NCIT Codesystem#C134022)

StructureDefinition Work Group: brr

url: http://hl7.org/fhir/us/pq-cmc-fda/PlanDefinition/cc82a0ce-b72f-4d58-8ea0-6f323e2a9a93

identifier: ExampleSpecification2

version: 0.1.20

title: Quality Specification for an API

status: active

subject: urn:uuid:5f66b17e-e3c0-4ee4-8106-59faa34d70f7

date: 2022-12-08

publisher: HL7 International / Biomedical Research and Regulation

contact: HL7 International / Biomedical Research and Regulation: http://www.hl7.org/Special/committees/rcrim,brr@lists.HL7.org

UseContexts

-CodeValue[x]
*Workflow Setting (Details: http://terminology.hl7.org/CodeSystem/usage-context-type code workflow = 'Workflow Setting', stated as 'Workflow Setting')Tentatively Approved (Dummy NCIT Codesystem#C134010)

jurisdiction: United States of America (ISO 3166-1 Codes for the representation of names of countries and their subdivisions — Part 1: Country code#US)

approvalDate: 2022-12-08

goal

id

b304ed45-5295-4082-9827-f20e1ff0d1d3

description: Negative ()

addresses: Release (Dummy NCIT Codesystem#C134029), Stability (Dummy NCIT Codesystem#C134030)

Targets

-Detail[x]
*Negative (Dummy NCIT Codesystem#C48793 "EQ")

goal

id

d4e38c52-30f6-4bb7-ab84-99439a7266ce

description: Negative ()

addresses: Release (Dummy NCIT Codesystem#C134029), Stability (Dummy NCIT Codesystem#C134030)

Targets

-Detail[x]
*Negative (Dummy NCIT Codesystem#C48793 "EQ")

goal

id

2abf1f19-e1b1-42e4-b943-79f5fa1642fe

description: Negative ()

addresses: Release (Dummy NCIT Codesystem#C134029), Stability (Dummy NCIT Codesystem#C134030)

Targets

-Detail[x]
*Negative (Dummy NCIT Codesystem#C48793 "EQ")

goal

id

c0ed4a79-8f40-4d26-8845-4cea166fb627

description: NMT 10 colony-forming units ()

addresses: Release (Dummy NCIT Codesystem#C134029), Stability (Dummy NCIT Codesystem#C134030)

Targets

-Detail[x]
*10 colony forming units (Details: http://hl7.org/fhir/us/pq-cmc-fda/CodeSystem/cmc-ncit-dummy code C68742 = '[CFU]')

goal

id

442983b5-bbc3-4534-9f1b-5ae5e4c531c1

description: NMT 100 colony-forming units ()

addresses: Release (Dummy NCIT Codesystem#C134029), Stability (Dummy NCIT Codesystem#C134030)

Targets

-Detail[x]
*100 colony forming units (Details: http://hl7.org/fhir/us/pq-cmc-fda/CodeSystem/cmc-ncit-dummy code C68742 = '[CFU]')

action

id

997a8ec6-eabf-41a3-b166-ddc3dfb35c27

Test Order | Stage Sequence Order: 1

title: Microbiological Examination of Nonsterile Products

code: Visual (Dummy NCIT Codesystem#C96102 "Compendial")

reason: Microbial Limits (Hierarchical Test Category Codes#TC13)

Documentations

-TypeLabel
*documentationUSP <61>

Actions

-ExtensionLinkIdPrefixTitleGoalId
*997a8ec6-eabf-41a3-b166-ddc3dfb35c27Stage 1Staphylococcus aureusb304ed45-5295-4082-9827-f20e1ff0d1d3
*997a8ec6-eabf-41a3-b166-ddc3dfb35c27Stage 2Pseudomonas aeruginosad4e38c52-30f6-4bb7-ab84-99439a7266ce
*997a8ec6-eabf-41a3-b166-ddc3dfb35c27Stage 3Bacillus subtilis2abf1f19-e1b1-42e4-b943-79f5fa1642fe
*997a8ec6-eabf-41a3-b166-ddc3dfb35c27Stage 4Total Aerobic Microbial Count (TAMC)c0ed4a79-8f40-4d26-8845-4cea166fb627
*997a8ec6-eabf-41a3-b166-ddc3dfb35c27Stage 5Total Yeasts and Molds Count (TYMC)442983b5-bbc3-4534-9f1b-5ae5e4c531c1